Replies to post #304186 on Avid Bioservices Inc (CDMO)

[EndoTarget]

Ask realist1 and his comeback!!!!

[keep_trying]

James, the "why" for naked shorting doesn't need an answer, because suppressing the share price can serve agendas for several factions on that list. Considering the high volume, the naked shorting was likely a violation of market rules. The key question is, which faction(s) did 51% naked shorting today? Then there is the three shares trade after hours that drops the posted trade price close a dime lower. That came right after a large trade so the chart looks like it was large volume at the lower pps. Yikes! Do such things matter?

Best wishes and IMO.
KT

[biopharm]

James, what do you think of the chances that Ronin Capital would have attempted to place Dr Bernhard Hampl in the Peregrine mix?

"Dr. Hampl has been a Director of Cambrex Corporation since October 27, 2016. He has been a Member of Chief Executive Officer Advisory Board at Great Point Partners, LLC since 2011."
http://www.bloomberg.com/research/stocks/private/person.asp?personId=2263705&privcapId=18613

Dr Bernhard Hampl joined GPP in 2011 as advisory to CEO
http://www.gppfunds.com/team/Bernhard_Hampl.html

I don't trust GPP since they backed big money into CSM in Fargo, suspect at center of the sabotage against Peregrine ....so I also don't trust Dr Bernhard Hampl and BKH Pharma Services, as you will notice Dr Hampl ties directly in there as it is controlled by Dr Hampl and Winship Service Corporation


https://www.ct-registry.com/967722-bkh-pharma-services-llc

http://www.shipmangoodwin.com/mobile/showbio.aspx?show=6991

------

If anyone forgets and does not realize the sabotage brought against Peregrine....by CSM with it's leader CEO Gerald Finken taking over for Jeanette Bleecker who admits to swapping drugs and FORCING Peregrine and PS Targeting to be stalled should ask WHY Greatpoint Partners has infused money into CSM ?????

-------

Great Point Partners Completes Growth Recapitalization of Clinical Supplies Management

October 12, 2016

GREENWICH, CT and MALVERN, PA — Great Point Partners ("GPP") today announced a growth recapitalization of Clinical Supplies Management ("CSM" or the "Company"). CSM is a leading provider of clinical trials drug packaging, labeling and logistics solutions to the global life science, pharmaceutical and biotechnology industries. CSM was founded in 1997 by Gerald Finken, a pharmacist with over 35 years of experience in the clinical supplies industry. CSM has grown from a niche provider of returns and reconciliations, to a full service solutions provider able to manage the full spectrum of a pharmaceutical company’s needs for clinical trials materials management.
"CSM has a superb reputation in the clinical trial management industry and is constantly evolving to meet the needs of their clients," said Rohan Saikia, Principal of Great Point Partners. "Our investment and partnership with CSM will enable the Company to invest further in its infrastructure and management team as well as execute on an accelerated growth strategy including expanded service offerings overseas to meet the needs of CSM’s global clients. As part of our partnership with CSM, Gerald will become Chief Scientific Officer and industry veteran Scott Houlton will join as CEO." Scott Houlton most recently served as President of Development and Clinical Services at Catalent and prior to Catalent, Mr. Houlton held leadership roles at Aptuit and Quintiles Transnational.
"Gerald has done a phenomenal job leading CSM through two decades of growth" added Stephen Weaver, Vice President of Great Point Partners. "Great Point’s knowledge in outsourced pharmaceutical services and ability to source and execute strategic tuck-in acquisitions will help transform the business into a worldwide leader in clinical trial packaging and labeling."
"We are very pleased to partner with Great Point Partners and leverage their industry expertise to grow CSM" said Gerald Finken. "Our goal of delivering CSM’s On-Demand services worldwide will now become a reality."

http://www.gppfunds.com/news/news_archive/2016/release_20161012.html

It is very difficult...I think....to hide puzzle pieces like this ....and ties to Cambrex should make ALL ask what are the intentions of Ronin ?? Especially with ties to CSM in Fargo ND

Will Peregrine use facts like this to their advantage...

Will a 3rd party jump into this race and reveal themselves?? I think yes

I would want all Fargo sealed records opened up....before changing BODs because those records may help shareholders make up their mind

[exwannabe]

KT, the Naked Shorts topped themselves again today. I wonder where the share price would be without them.

In a stock with little interest all you have is day traders who are 50-50 and market makers who have to sell when somebody hits their asks.

That is why the short interest trends to near 50% for such.

An it is not "naked" short. A short can not even legally be naked for 3 days, and at the data you are looking at is current.

The stock has a low PPS because it deserves it.